Susquehanna Fundamental Investments, LLC Harvard Bioscience Inc Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.33 - $3.92 $113,459 - $190,884	-48,695 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.16 - $7.14 $90,258 - $124,892	-17,492 Reduced 26.43%	48,695 $302,000
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $75,204 - $96,573	-11,806 Reduced 15.14%	66,187 $467,000
Q3 2021 Nov 15, 2021	BUY	$6.98 - $8.47 $210,077 - $254,921	30,097 Added 62.84%	77,993 $544,000
Q2 2021 Aug 11, 2021	BUY	$5.44 - $8.4 $260,554 - $402,326	47,896 New	47,896 $399,000

102

32M

1.2K

1.2K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $112M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.